Caxton Associates (New York)’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,230	Closed	-$207K	–	527
2022 Q4	$207K	Buy	+33,230	New	+$207K	0.01%	357
2022 Q3	–	Sell	-19,768	Closed	-$126K	–	516
2022 Q2	$126K	Buy	+19,768	New	+$126K	0.01%	485